Target Price | $841.50 |
Price | $768.57 |
Potential | 9.49% |
Number of Estimates | 19 |
19 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $841.50. This is 9.49% higher than the current stock price. The highest price target is $987.00 28.42% , the lowest is $585.11 23.87% . | |
A rating was issued by 26 analysts: 21 Analysts recommend Axon Enterprise Inc to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 9.49% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
20 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.7b . This is 13.48% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.8b 18.71% , the lowest is $2.6b 7.67% .
This results in the following potential growth metrics:
2024 | $2.1b | 33.44% |
---|---|---|
2025 | $2.7b | 30.32% |
2026 | $3.3b | 23.36% |
2027 | $4.0b | 19.09% |
19 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $695m . This is 2,192.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $761m 2,410.07% , the lowest is $649m 2,042.84% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $112m | 41.87% |
---|---|---|
2025 | $695m | 522.04% |
2026 | $893m | 28.61% |
2027 | $1.2b | 30.86% |
2024 | 5.36% | 56.43% |
---|---|---|
2025 | 25.59% | 377.23% |
2026 | 26.68% | 4.26% |
2027 | 29.32% | 9.90% |
19 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $491m . This is 50.52% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $607m 86.13% , the lowest is $410m 25.55% .
This results in the following potential growth metrics and future Net Margins:
2024 | $377m | 114.49% |
---|---|---|
2025 | $491m | 30.27% |
2026 | $608m | 23.85% |
2027 | $714m | 17.39% |
2024 | 18.10% | 60.74% |
---|---|---|
2025 | 18.10% | 0.02% |
2026 | 18.17% | 0.39% |
2027 | 17.91% | 1.43% |
19 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.31 . This is 58.94% higher than earnings per share in the financial year 2024. The highest EPS forecast is $7.80 96.47% , the lowest is $5.26 32.49% .
This results in the following potential growth metrics and future valuations:
2024 | $4.80 | 106.01% |
---|---|---|
2025 | $6.31 | 31.46% |
2026 | $7.81 | 23.77% |
2027 | $9.17 | 17.41% |
Current | 193.59 | 189.07% |
---|---|---|
2025 | 121.82 | 37.07% |
2026 | 98.36 | 19.26% |
2027 | 83.79 | 14.81% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 22.15 and an P/S ratio of 22.23 .
This results in the following potential growth metrics and future valuations:
Current | 25.14 | 109.85% |
---|---|---|
2025 | 22.15 | 11.90% |
2026 | 17.96 | 18.94% |
2027 | 15.08 | 16.03% |
Current | 25.23 | 107.57% |
---|---|---|
2025 | 22.23 | 11.88% |
2026 | 18.02 | 18.94% |
2027 | 15.13 | 16.03% |
Axon Enterprise Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Buy
➜
Buy
|
Unchanged | Aug 06 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2025 |
Craig-Hallum |
Hold
➜
Buy
|
Upgrade | Aug 05 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Aug 05 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Aug 05 2025 |
JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Jul 22 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Aug 06 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Aug 05 2025 |
Upgrade
Craig-Hallum:
Hold
➜
Buy
|
Aug 05 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Aug 05 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Aug 05 2025 |
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Jul 22 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.